Evidence That IRS-2 Phosphorylation Is Required for Insulin Action in Hepatocytes*

Insulin receptor substrates (IRSs) are tyrosine-phosphorylated following stimulation with insulin, insulin-like growth factors (IGFs), and interleukins. A key question is whether different IRSs play different roles to mediate insulin’s metabolic and growth-promoting effects. In a novel system of insulin receptor-deficient hepatocytes, insulin fails to (i) stimulate glucose phosphorylation, (ii) enhance glycogen synthesis, (iii) suppress glucose production, and (iv) promote mitogenesis. However, insulin’s ability to induce IRS-1 and gab-1 phosphorylation and binding to phosphatidylinositol (PI) 3-kinase is unaffected, by virtue of the compensatory actions of IGF-1 receptors. In contrast, phosphorylation of IRS-2 and generation of IRS-2/PI 3-kinase complexes are markedly reduced. Thus, absence of insulin receptors selectively reduces IRS-2, but not IRS-1 phosphorylation, and the impairment of IRS-2 activation is associated with lack of insulin effects. To address whether phosphorylation of additional IRSs is also affected, we analyzed phosphotyrosine-containing proteins in PI 3-kinase immunoprecipitates from insulin-treated cells. However, these experiments indicate that IRS-1 and IRS-2 are the main PI 3-kinase-bound proteins in hepatocytes. These data identify IRS-2 as the main effector of both the metabolic and growth-promoting actions of insulin through PI 3-kinase in hepatocytes, and IRS-1 as the main substrate mediating the mitogenic actions of IGF-1 receptors.

[1]  Mark D. Johnson,et al.  Early neonatal death in mice homozygous for a null allele of the insulin receptor gene , 1996, Nature Genetics.

[2]  F. Bosch,et al.  Correction of diabetic alterations by glucokinase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Morel,et al.  Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes. , 1995, The Journal of clinical investigation.

[4]  Y. Yazaki,et al.  Site-directed mutagenesis of the juxtamembrane domain of the human insulin receptor. , 1993, The Journal of biological chemistry.

[5]  G. M. Di Guglielmo,et al.  Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf‐1 by EGF but not insulin in liver parenchyma. , 1994, The EMBO journal.

[6]  D. Accili Insulin Receptor Knock-Out Mice , 1997, Trends in Endocrinology & Metabolism.

[7]  N. Sonenberg,et al.  Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice , 1996, Molecular and cellular biology.

[8]  C. Kahn,et al.  The 60 kDa insulin receptor substrate functions like an IRS protein (pp60IRS3) in adipose cells. , 1997, Biochemistry.

[9]  T. Yagi,et al.  Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 , 1994, Nature.

[10]  E. Van Obberghen,et al.  Insulin Receptor Substrate-2 Binds to the Insulin Receptor through Its Phosphotyrosine-binding Domain and through a Newly Identified Domain Comprising Amino Acids 591786 (*) , 1996, The Journal of Biological Chemistry.

[11]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[12]  M. White,et al.  Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1 , 1993, Molecular and cellular biology.

[13]  G. Lienhard,et al.  Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. White,et al.  IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. , 1993, Science.

[15]  Andrius Kazlauskas,et al.  PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase , 1994, Nature.

[16]  D. Accili,et al.  Tissue distribution and subcellular localization of an endogenous substrate (pp 120) for the insulin receptor-associated tyrosine kinase. , 1986, Endocrinology.

[17]  J. Pessin,et al.  Insulin receptor substrate-1 (IRS1) and Shc compete for a limited pool of Grb2 in mediating insulin downstream signaling. , 1994, The Journal of biological chemistry.

[18]  T. Shimazu,et al.  Effects of wortmannin on increased glucose transport by insulin and norepinephrine in primary culture of brown adipocytes. , 1994, Biochemical and Biophysical Research Communications - BBRC.

[19]  G. Bifulco,et al.  In Skeletal Muscle, Glucose Storage and Oxidation Are Differentially Impaired by the IR1152 Mutant Receptor* , 1997, The Journal of Biological Chemistry.

[20]  R. Roth,et al.  Insulin stimulates the kinase activity of RAC‐PK, a pleckstrin homology domain containing ser/thr kinase. , 1995, The EMBO journal.

[21]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[22]  G. Lienhard,et al.  A Novel 160-kDa Phosphotyrosine Protein in Insulin-treated Embryonic Kidney Cells Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.

[23]  M. Nakafuku,et al.  Signal transduction pathways from insulin receptors to Ras. Analysis by mutant insulin receptors. , 1994, The Journal of biological chemistry.

[24]  C. Kahn,et al.  Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous for IR and IRS-1 Null Alleles , 1997, Cell.

[25]  D. Accili,et al.  Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. , 1997, The Journal of clinical investigation.

[26]  J. Chou Establishment of rat fetal liver lines and characterization of their metabolic and hormonal properties: use of temperature-sensitive SV40 virus. , 1985, Methods in enzymology.

[27]  C. Kahn,et al.  A mutant insulin receptor induces formation of a Shc-growth factor receptor bound protein 2 (Grb2) complex and p21ras-GTP without detectable interaction of insulin receptor substrate 1 (IRS1) with Grb2. Evidence for IRS1-independent p21ras-GTP formation. , 1994, The Journal of biological chemistry.

[28]  A. Louvi,et al.  Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[30]  Ling-mei Wang,et al.  Interaction of Insulin Receptor Substrate-2 (IRS-2) with the Insulin and Insulin-like Growth Factor I Receptors , 1996, The Journal of Biological Chemistry.

[31]  C. Kahn,et al.  Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells , 1997, Molecular and cellular biology.

[32]  E. Van Obberghen,et al.  Tyr624 and Tyr628 in Insulin Receptor Substrate-2 Mediate Its Association with the Insulin Receptor* , 1997, The Journal of Biological Chemistry.

[33]  J. Blenis,et al.  Insulin receptor substrate-1 mediates phosphatidylinositol 3'-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation. , 1994, The Journal of biological chemistry.

[34]  F. Grigorescu,et al.  Involvement of phosphoinositide 3‐kinase in insulin‐ or IGF‐1‐induced membrane ruffling. , 1994, The EMBO journal.

[35]  M. Ridderstråle,et al.  Essential role of phosphatidylinositol 3‐kinase in insulin‐induced activation and phosphorylation of the cGMP‐inhibited cAMP phosphodiesterase in rat adipocytes studies using the selective inhibitor wortmannin , 1994, FEBS letters.

[36]  C. Kahn,et al.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.

[37]  J. Berger,et al.  PI 3-kinase activation is required for insulin stimulation of glucose transport into L6 myotubes. , 1994, Biochemical and biophysical research communications.

[38]  J. Flier,et al.  Insulin-like growth factor I (rhIGF-I) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitus. , 1995, Diabetes research and clinical practice.

[39]  M. White,et al.  The IRS‐signalling system during insulin and cytokine action , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[40]  P. Cohen,et al.  Mechanism of activation of protein kinase B by insulin and IGF‐1. , 1996, The EMBO journal.

[41]  M. White,et al.  Regulation of Phosphatidylinositol 3′-Kinase by Tyrosyl Phosphoproteins , 1995, The Journal of Biological Chemistry.

[42]  R. O’Brien,et al.  Phosphatidylinositol 3-Kinase, but Not p70/p85 Ribosomal S6 Protein Kinase, Is Required for the Regulation of Phosphoenolpyruvate Carboxykinase (PEPCK) Gene Expression by Insulin , 1995, The Journal of Biological Chemistry.

[43]  M. Kasuga,et al.  Ras-independent and wortmannin-sensitive activation of glycogen synthase by insulin in Chinese hamster ovary cells , 1995, The Journal of Biological Chemistry.

[44]  X Wang,et al.  Activation of translation initiation factor eIF2B by insulin requires phosphatidyl inositol 3‐kinase , 1997, FEBS letters.

[45]  William Arbuthnot Sir Lane,et al.  Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.

[46]  B. Burgering,et al.  Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction , 1995, Nature.

[47]  K. Siddle,et al.  Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: implications for glucose metabolism , 1997, Diabetologia.

[48]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[49]  J. Olefsky,et al.  Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. , 1994, The Journal of biological chemistry.

[50]  T. Okada,et al.  Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. , 1994, The Journal of biological chemistry.

[51]  G. Lienhard,et al.  The 60-kDa Phosphotyrosine Protein in Insulin-treated Adipocytes Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.

[52]  B. Lamothe,et al.  Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. , 1996, The EMBO journal.

[53]  D. Accili,et al.  Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. , 1997, Developmental biology.

[54]  M. Birnbaum,et al.  The Effects of Wortmannin on Rat Skeletal Muscle , 1995, The Journal of Biological Chemistry.

[55]  A. Saltiel,et al.  Regulation of System A Amino Acid Transport in 3T3-L1 Adipocytes by Insulin* , 1998, The Journal of Biological Chemistry.

[56]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[57]  Yasuhiro Watanabe,et al.  Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells. , 1995, Biochemical and biophysical research communications.

[58]  A. Godwin,et al.  A Grb2-associated docking protein in EGF- and insulin-receptor signalling , 1996, Nature.

[59]  M. White,et al.  IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85. , 1992, Proceedings of the National Academy of Sciences of the United States of America.